Tirofiban
Back to searchMolecule Structure
Scientific Name
Tirofiban
Description of the Drug
Tirofiban is a platelet aggregation inhibitor used to prevent thrombotic events in non-ST elevated acute coronary syndrome.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00775
http://www.drugbank.ca/drugs/DB00775
Brand Name(s)
Not Available
Company Owner(s)
Gland Pharma Ltd, Medicure International Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Integrin alpha-IIb/beta-3 | PROTEIN COMPLEX | INHIBITOR | CHEMBL2093869 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3685 | ||
| PharmGKB | PA451698 | ||
| Human Metabolome Database | HMDB0014913 | ||
| DrugBank | DB00775 | ||
| PubChem: Thomson Pharma | 14857107 | 14783655 | |
| PubChem | 40466968 | 60947 | |
| LINCS | LSM-45871 | ||
| Nikkaji | J523.557J | ||
| PDBe | AGG | ||
| BindingDB | 50004058 | ||
| EPA CompTox Dashboard | DTXSID20162730 | ||
| DrugCentral | 2680 | ||
| Brenda | 117831 | ||
| ChemicalBook | CB9169083 | ||
| Guide to Pharmacology | 6586 | ||
| rxnorm | TIROFIBAN HYDROCHLORIDE | AGGRASTAT | TIROFIBAN |
| KEGG Ligand | C07965 | ||
| ChEBI | 9605 | ||
| ZINC | ZINC000003806104 |
